Warfarin
Back to search| Scientific Name: | Warfarin |
| Brand Name: | Coumadin, Jantoven |
| Company Owner: | Pharmaceutical research assoc inc, Bristol myers squibb pharma co, Usl pharma inc, Abbott laboratories pharmaceutical products div, Barr laboratories inc, Mylan pharmaceuticals inc, Pliva inc, Sandoz inc, Taro pharmaceuticals inc, Watson laboratories inc, Zydus pharmaceuticals usa inc |
| Mechanism Of Action | Warfarin is a [vitamin K] antagonist which acts to inhibit the production of vitamin K by vitamin K epoxide reductase. |
| Description of the Drug: | Warfarin is a vitamin K antagonist used to treat venous thromboembolism, pulmonary embolism, thromboembolism with atrial fibrillation, thromboembolism with cardiac valve replacement, and thromboembolic events post myocardial infarction. |
| Protein Data Bank: | Not Available |
Source: DrugBank Online – DrugBank.com. Retrieved 2023-01-23 from https://go.drugbank.com/drugs/DB00682
